Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.
Venn Life Sciences Stock Up 7.0 %
The company has a debt-to-equity ratio of 35.83, a quick ratio of 1.48 and a current ratio of 2.30. The firm has a market capitalization of £4.89 million and a P/E ratio of -2.14. The stock has a fifty day moving average price of GBX 6.85 and a two-hundred day moving average price of GBX 6.85.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Stories
- Five stocks we like better than Venn Life Sciences
- What is the NASDAQ Stock Exchange?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What is the Nasdaq? Complete Overview with History
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Investing in Travel Stocks Benefits
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.